RARRES1 and breast cancer: We assessed the levels of methylation at sequences flanking RARRES1 promoter in 18 pairs of breast tumor cores plus adjacent benign tissues as well as in breast cancer cell lines and have discovered methylation at two regions can exert strikingly distinct epigenetic outcomes.